Search results
For 175 years, Pfizer has been a trusted partner in healthcare – discovering, developing, and delivering medical breakthroughs to prevent, treat, and cure some of the world’s most vexing conditions and diseases. Learn more about our history.
- Careers
We’ve transformed growth and development at Pfizer to ensure...
- Investors
Forward-Looking Statements of Pfizer Inc. This webcast may...
- Media
Pfizer surveyed adults in 10 countries across the Global...
- Partners
Pfizer is a global leader in discovering and developing...
- Contact Us
Pfizer Inc. 66 Hudson Boulevard East New York, NY 10001-2192...
- Products
In this section find an overview of our Pfizer Products and...
- Science
Programs & Initiatives This Rotational R&D Program Allows...
- About
Pfizer purchases a nearby vacant ice plant, and employees...
- Careers
Homepage | Pfizer Singapore. Science Contact Us. Breakthroughs that Change Patients' Lives Pfizer Colleagues Work to Challenge the Mos t Feared Diseases of Our Time Learn More Coronavirus Resources Current information on our scientific progress Learn More Innovative Therapies for Tomorrow Translating advanced science and technologies into ...
Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.
As one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, government agencies and local communities to expand access to reliable and affordable health care.
We’ve transformed growth and development at Pfizer to ensure that everyone can follow a path to their dream career, whether that’s climbing a traditional ladder or “zig-zagging” their way to a new role. At Pfizer, you’ll lead your journey.
Pfizer Inc. and BioNTech SE announced today they have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) to understand the effect of a booster on immunity against COVID-19 caused by the circulating and potential newly emerging SARS-CoV-2 variants.
Dec 11, 2020 · COMIRNATY is the first COVID-19 vaccine to be granted FDA approval. Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose. More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020.